Background
At a recent conference organised by the Institute of Actuaries of India,1 India’s insurance sector regulator IRDAI2 indicated that it intends to align the upcoming Indian Risk-Based Capital (RBC) framework with Ind AS financial reporting.3
The objective is to have a single balance sheet that can be used for both financial reporting and solvency assessment, minimising the confusion that different reporting bases can create for company managements, boards, regulators, investors and analysts.
This is an interesting objective because accounting and solvency reporting serve fundamentally different purposes:
-
Financial reporting / accounting seeks to present an insurer’s financial position and performance in accordance with accounting standards, primarily for shareholders. Under Ind AS (specifically Ind AS 117), insurance contracts are measured using current estimates of future cash flows, an adjustment for non-financial risk and, where applicable, a contractual service margin (CSM) representing unearned profit.
-
Risk-Based Capital, on the other hand, seeks to assess whether an insurer has sufficient financial resources to withstand adverse developments. This requires determining the capital available to absorb losses, estimating potential losses from different risks and comparing the two. It approaches the insurer’s financial position from a regulatory perspective, with policyholder protection as its primary objective.
Most major solvency regimes, including Solvency II and the IAIS4 Insurance Capital Standard (ICS), prescribe their own regulatory valuation requirements, instead of using the accounting balance sheet.
Canada provides a particularly useful precedent for the converged approach that IRDAI is aiming for. Its Life Insurance Capital Adequacy Test (LICAT)5 uses IFRS financial reporting as the starting point for solvency assessment, with specified regulatory adjustments.
In this series, we will explore how LICAT reconciles the two frameworks. We begin with the Contractual Service Margin (CSM).
How LICAT uses the IFRS balance sheet
LICAT is the capital adequacy framework prescribed by Canada’s Office of the Superintendent of Financial Institutions (OSFI) for federally regulated life insurers.
Section 1.3 of the LICAT guideline specifies that the starting point for determining available capital, required capital and other solvency components is the financial information prepared under Canadian Generally Accepted Accounting Principles (Canadian GAAP).6 For Canadian insurers, Canadian GAAP is effectively IFRS. IFRS 17 was adopted for insurance contracts in 2023.
This allows insurers to use their existing accounting valuations, cash-flow projections and contract boundaries as the foundation for solvency calculations.
LICAT makes broad adjustments where the accounting treatment would otherwise interfere with the measurement of available capital or the risks facing the insurer. One such adjustment concerns CSM.
What is the CSM, and how does LICAT treat it?
Under IFRS 17, the CSM represents the unearned profit on a group of insurance contracts. Rather than recognising expected future profits immediately, the insurer carries them as part of the insurance contract liability and releases them into earnings as insurance services are provided.
Consider a simplified insurance portfolio with the following balances:
| Component | Amount |
|---|---|
| Best Estimate Liability (BEL) | 70 |
| Risk Adjustment (RA) | 10 |
| Contractual Service Margin (CSM) | 20 |
| Total IFRS 17 liability | 100 |
The CSM of 20 represents expected future profit that has not yet been recognised in accounting earnings.
From a solvency perspective, however, this amount is different from the insurer’s expected claims and expenses. It is not an additional cash outflow that the insurer expects to pay to policyholders.
LICAT therefore removes CSM from the regulatory insurance liability and recognises it within available capital.
More precisely, section 2.1.1 of LICAT makes the following adjustments in calculating Adjusted Retained Earnings, a component of Gross Tier 1 capital:
- CSM reported as a liability is added.
- CSM reported as an asset is subtracted.
This signed treatment is important, particularly for reinsurance contracts held, where CSM may appear on either side of the balance sheet.
In our simplified example, removing CSM reduces the regulatory liability from 100 to 80 and increases capital by 20.
In short, LICAT reclassifies CSM from an accounting liability into regulatory capital.
Why not simply retain CSM within liabilities?
There is an alternative approach.
One could retain the IFRS 17 liability, including CSM, and recalculate that liability under each prescribed solvency stress.
Under IFRS 17’s General Measurement Model (GMM), certain adverse changes in expected future cash flows relating to future service are absorbed by the CSM before a loss is recognised in profit or loss.
At first glance, allowing this mechanism to operate in the solvency calculation might seem reasonable. If future expected profits can absorb adverse experience, why should the capital calculation ignore this?
There are, however, three significant problems.
1. CSM absorption can distort the aggregation of capital charges
Consider the following example.
An insurer has a BEL of 70, RA of 10 and CSM of 20. We consider two independent regulatory stresses, A and B, each of which increases the BEL by 15.
For simplicity, we hold RA constant and assume that the changes in BEL are eligible to be absorbed by CSM under IFRS 17.
| Component | Base | Stress A | Stress B | Both stresses |
|---|---|---|---|---|
| BEL | 70 | 85 | 85 | 100 |
| RA | 10 | 10 | 10 | 10 |
| CSM | 20 | 5 | 5 | 0 |
| Total liability | 100 | 100 | 100 | 110 |
| Reduction in equity | — | 0 | 0 | 10 |
Under Stress A, the increase in BEL is offset by the reduction in CSM. The total accounting liability remains unchanged, so there is no reduction in equity.
Exactly the same thing happens under Stress B.
However, when the two stresses occur together, the total increase in BEL is 30, exceeding the available CSM of 20. The insurer now suffers a reduction in equity of 10.
This creates a problem for an RBC framework in which standalone risk capital charges are calculated separately and subsequently aggregated.
Both standalone capital charges are zero. No conventional aggregation formula applied to these zero charges can recover the combined loss of 10.
The same CSM has effectively been used twice to absorb different standalone stresses.
This does not mean that allowing CSM to absorb losses is inherently wrong. A framework that models the joint distribution of risks and the exhaustion of CSM across them could, in principle, recognise this effect. However, doing so would require a more sophisticated aggregation methodology, potentially including joint stresses and rules governing which contract groups can absorb different losses.
LICAT avoids this problem by excluding CSM from the stressed liability calculations.
In the example above, the two standalone stresses would each generate a liability increase of 15, which can then be aggregated using the prescribed RBC methodology.
2. Solvency becomes sensitive to the IFRS 17 transition approach
IFRS 17 permits different approaches for establishing opening balances on transition, depending on the information available to an insurer.
These approaches may result in different amounts being allocated between CSM and retained earnings, even where the underlying economic position is broadly similar.
Consider two insurers, or two possible transition outcomes for the same insurer:
| Component | Outcome A | Outcome B |
|---|---|---|
| Assets | 150 | 150 |
| Fulfilment cash flows | 100 | 100 |
| CSM | 30 | 10 |
| Accounting equity | 20 | 40 |
| Equity + CSM | 50 | 50 |
The underlying assets and fulfilment cash flows are identical.
However, if the solvency framework recognises only accounting equity as available capital, Outcome A produces capital of 20, while Outcome B produces capital of 40.
This is a substantial difference arising entirely from the accounting allocation between retained earnings and CSM.
By including eligible CSM in the same capital tier as retained earnings, LICAT eliminates this particular distortion. Both outcomes produce capital of 50.
This does not remove every difference that may arise from transition, including differences in cash-flow estimates or tax effects. But it prevents the allocation between CSM and retained earnings, by itself, from determining the insurer’s solvency position.
The treatment of CSM as Tier 1 capital is therefore particularly important. Recognising CSM only as lower-quality capital, or subjecting it to an arbitrary haircut, could reintroduce differences between otherwise equivalent transition outcomes.
3. Calculating stressed CSM is operationally complicated
The third problem is practical.
Recalculating a stressed BEL is a relatively familiar actuarial exercise. The insurer changes the relevant assumptions, projects the revised cash flows and discounts them to determine the stressed liability.
Recalculating CSM under stress is considerably more involved.
Under IFRS 17, CSM is maintained at the group-of-contracts level. Its movement depends on whether changes relate to future service, the measurement model being applied, the exhaustion of existing CSM and the recognition or reversal of losses.
For contracts measured under the Variable Fee Approach (VFA), the calculation must also reflect the mechanics of the variable fee and changes in underlying items. Reinsurance contracts held introduce further complications.
A regulatory framework that requires stressed CSM calculations would therefore require insurers to process their prescribed stresses through much of the IFRS 17 accounting machinery.
This is not necessarily straightforward even for insurers that have already implemented IFRS 17 successfully.
An accounting engine designed to produce quarterly financial statements may not be equipped to run numerous regulatory stress scenarios, particularly where these involve changes to multiple assumptions simultaneously.
The insurer would need either substantial enhancements to its accounting engine or a separate implementation of the relevant CSM calculations.
Removing CSM from the regulatory liabilities avoids this dependency. Insurers still need reliable best-estimate cash flows and models capable of applying the regulatory stresses, but they do not need to recreate the IFRS 17 accounting calculations for every stress scenario.
What does this mean for India?
The objective of aligning financial reporting and solvency assessment is sensible. Two entirely different balance sheets create reconciliation difficulties and make it harder for stakeholders to understand an insurer’s financial position.
The LICAT example demonstrates that this is feasible, at least to the extent of using the IFRS / Ind AS balance sheet as a starting point and then applying targeted adjustments. This is also how the solvency figures under IRDAI’s current factor-based regime are calculated using the existing Indian GAAP financial statements.
In subsequent articles, we will examine how LICAT reconciles other aspects of IFRS reporting with its solvency requirements.
Footnotes
-
Current Issues in General Insurance, conference organised by the Institute of Actuaries of India (IAI), held on 27–28 October 2026. ↩
-
Insurance Regulatory and Development Authority of India ↩
-
Indian Accounting Standards (Ind AS) are India’s accounting standards, notified under the Companies Act, 2013 and substantially converged with International Financial Reporting Standards (IFRS). Ind AS 117, governing insurance contracts, is based on IFRS 17. ↩
-
International Association of Insurance Supervisors (IAIS), the international standard-setting body for insurance supervision. ↩
-
Canadian GAAP refers to Canadian Generally Accepted Accounting Principles. Canada adopted IFRS as Canadian GAAP for publicly accountable enterprises, including insurers, from 2011. IFRS 17 became effective for Canadian insurers in 2023. ↩
In this article